Trial
NCT01826864
Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
Genzyme, a Sanofi Company; National Cancer Institute (NCI)
Condition
Stage IB Melanoma
Intervention
sargramostim
Why stopped
No participants enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-27